Literature DB >> 25634630

Hospital rapid response team and patients with life-limiting illness: a multicentre retrospective cohort study.

Merlina Sulistio1, Michael Franco2, Amanda Vo3, Peter Poon4, Leeroy William5.   

Abstract

BACKGROUND: Approximately one-third of rapid response team consultations involve issues of end-of-life care. We postulate a greater occurrence in patients with a life-limiting illness, in whom the opportunity for advance care planning and palliative care involvement should be offered. AIMS: We aim to review the characteristics and compare outcomes of rapid response team consultations on patients with and without a life-limiting illness. DESIGN/
SETTING: A 3-month retrospective cohort study of all rapid response team consultations was conducted. The sample population included all adult inpatients in a major teaching hospital network.
RESULTS: We identified 351 patients - including 139 with a life-limiting illness - receiving a total of 456 rapid response team consultations. The median time from admission to the first rapid response team consultation was 3 days. Patients with a life-limiting illness had a significantly higher mortality rate (41.7% vs 13.2%), were older (72.6 vs 63.5 years), more likely to come from a residential aged-care facility (29.5% vs 4.1%) and had a shorter hospital stay (10 vs 13 days). Rapid response team consultations resulted in a change to more palliative goals of care in 28.5% of patients, of whom two-thirds had a life-limiting illness.
CONCLUSION: Patients with a life-limiting illness had worse outcomes post-rapid response team consultation. Our findings suggest that a routine clarification of goals of care for this cohort, within 3 days of hospital admission, may be advantageous. These discussions may provide clarity of purpose to treating teams, reduce the burden of unnecessary interventions and promote patient-centred care agreed upon in advance of any deterioration.
© The Author(s) 2015.

Entities:  

Keywords:  Rapid response team; advance care planning; cardiac arrest; end-of-life care; goals of care; resuscitation orders

Mesh:

Year:  2015        PMID: 25634630     DOI: 10.1177/0269216314560802

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

Review 1.  Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals.

Authors:  Nita Khandelwal; Ann C Long; Robert Y Lee; Cara L McDermott; Ruth A Engelberg; J Randall Curtis
Journal:  Lancet Respir Med       Date:  2019-05-20       Impact factor: 30.700

2.  Unplanned Admission to the ICU: A Qualitative Study Examining Family Member Experiences.

Authors:  Ann L Jennerich; Mara R Hobler; Rashmi K Sharma; Ruth A Engelberg; J Randall Curtis
Journal:  Chest       Date:  2020-06-02       Impact factor: 9.410

Review 3.  Advance care planning in the context of clinical deterioration: a systematic review of the literature.

Authors:  Wendy Pearse; Florin Oprescu; John Endacott; Sarah Goodman; Mervyn Hyde; Maureen O'Neill
Journal:  Palliat Care       Date:  2019-01-19

4.  Type of Track and Trigger system and incidence of in-hospital cardiac arrest: an observational registry-based study.

Authors:  Helen Hogan; Andrew Hutchings; Jerome Wulff; Catherine Carver; Elizabeth Holdsworth; Jerry Nolan; John Welch; David Harrison; Nick Black
Journal:  BMC Health Serv Res       Date:  2020-09-18       Impact factor: 2.655

5.  Quality of end-of-life care in general practice - a pre-post comparison of a two-tiered intervention.

Authors:  Katharina van Baal; Birgitt Wiese; Gabriele Müller-Mundt; Stephanie Stiel; Nils Schneider; Kambiz Afshar
Journal:  BMC Prim Care       Date:  2022-04-20

6.  Systematic development and adjustment of the German version of the Supportive and Palliative Care Indicators Tool (SPICT-DE).

Authors:  Kambiz Afshar; Angelika Feichtner; Kirsty Boyd; Scott Murray; Saskia Jünger; Birgitt Wiese; Nils Schneider; Gabriele Müller-Mundt
Journal:  BMC Palliat Care       Date:  2018-02-17       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.